“Rising Demand for Pre-packed Chromatography Columns”
- The demand for pre-packed chromatography columns is growing due to their ease of use, reduced setup time, and minimal risk of human error, making them ideal for contract manufacturing setups such as Lonza's biomanufacturing facilities
- These columns are increasingly used in monoclonal antibody purification processes, with companies such as Roche utilizing them for faster development in oncology therapeutics
- Vaccine developers adopt pre-packed columns to enhance efficiency in downstream processing, as seen in their widespread application during COVID-19 vaccine production by Moderna
- They support automation and scalability, which are critical for high-throughput environments in modern biopharmaceutical manufacturing and regulatory compliance
- Industry leaders such as GE Healthcare and Merck are expanding their portfolios of pre-packed columns to cater to growing demand in clinical and commercial purification workflows
